Is Blood Test Analyser Debug veilig?
Blood Test Analyser Debug — Nerq Trust Score 53.9/100 (D-beoordeling). Score gebaseerd op 5 independent trust signals.
Blood Test Analyser Debug is een software tool met een Nerq Vertrouwensscore van 53.9/100 (D), based on 5 onafhankelijke gegevensdimensies. Beveiliging: 0/100. Onderhoud: 1/100. Populariteit: 0/100. Gegevens afkomstig van meerdere openbare bronnen waaronder pakketregisters, GitHub, NVD, OSV.dev en OpenSSF Scorecard. Laatst bijgewerkt: n/a. Machineleesbare gegevens (JSON).
Is Blood Test Analyser Debug veilig?
Vertrouwensscore details — Blood Test Analyser Debug has a Nerq Trust Score of 53.9/100 (D). Measured across 5 independent trust signals.
Wat is de vertrouwensscore van Blood Test Analyser Debug?
Blood Test Analyser Debug heeft een Nerq Trust Score van 53.9/100 met het cijfer D. Deze score is gebaseerd op 5 onafhankelijk gemeten dimensies, waaronder beveiliging, onderhoud en community-adoptie.
Wat zijn de belangrijkste beveiligingsbevindingen voor Blood Test Analyser Debug?
Het sterkste signaal van Blood Test Analyser Debug is naleving met 79/100. Er zijn geen bekende kwetsbaarheden gedetecteerd.
Wat is Blood Test Analyser Debug en wie onderhoudt het?
| Ontwikkelaar | zaebbyte |
| Categorie | Health |
| Sterren | 1 |
| Bron | https://github.com/zaebbyte/blood-test-analyser-debug |
| Frameworks | langchain · crewai · openai |
| Protocols | rest |
Naleving van regelgeving
| EU AI Act Risk Class | MINIMAL |
| Compliance Score | 79/100 |
| Jurisdictions | Assessed across 52 jurisdicties |
Populaire alternatieven in health
What Is Blood Test Analyser Debug?
Blood Test Analyser Debug is a software tool in the health category: A comically overconfident AI-powered blood test report analyzer.. It has 1 GitHub stars. Nerq Trust Score: 54/100 (D).
Nerq independently analyzes every software tool, app, and extension across multiple trust signals including beveiliging vulnerabilities, onderhoud activity, license naleving, and gemeenschapsacceptatie.
How Nerq Assesses Blood Test Analyser Debug's Safety
Nerq's Trust Score is calculated from 13+ independent signals aggregated into five dimensies. Here is how Blood Test Analyser Debug performs in each:
- Beveiliging (0/100): Blood Test Analyser Debug's beveiliging posture is poor. This score factors in known CVEs, dependency vulnerabilities, beveiliging policy presence, and code signing practices.
- Onderhoud (1/100): Blood Test Analyser Debug is potentially abandoned. We track commit frequency, release cadence, issue response times, and PR merge rates.
- Documentation (0/100): Documentation quality is insufficient. This includes README completeness, API documentatie, usage examples, and contribution guidelines.
- Compliance (79/100): Blood Test Analyser Debug is broadly compliant. Assessed against regulations in 52 jurisdicties including the EU AI Act, CCPA, and GDPR.
- Community (0/100): Community adoption is limited. Gebaseerd op GitHub stars, forks, download counts, and ecosystem integrations.
The overall Trust Score of 53.9/100 (D) is the weighted combination of these measured signals. It is a measurement, not a pass/fail or suitability judgment — weigh the individual signals against your own requirements.
Who Typically Evaluates Blood Test Analyser Debug?
Blood Test Analyser Debug is commonly evaluated by:
- Developers and teams working with health tools
- Organizations evaluating AI tools for their stack
- Researchers exploring AI capabilities in this domain
How to read the signals: Blood Test Analyser Debug's measured signals (beveiliging 0/100, onderhoud 1/100, documentatie 0/100, community 0/100) are shown above. These are measurements, not a suitability judgment — weigh each signal against the requirements of your own use case and risk tolerance.
How to Verify Blood Test Analyser Debug's Safety Yourself
While Nerq provides automated trust analysis, we recommend these additional steps before adopting any software tool:
- Check the source code — Bekijk de repository's beveiliging policy, open issues, and recent commits for signs of active onderhoud.
- Scan dependencies — Use tools like
npm audit,pip-audit, orsnykto check for known vulnerabilities in Blood Test Analyser Debug's dependency tree. - Beoordeling permissions — Understand what access Blood Test Analyser Debug requires. Software tools should follow the principle of least privilege.
- Test in isolation — Run Blood Test Analyser Debug in a sandboxed environment before granting access to production data or systems.
- Monitor continuously — Use Nerq's API to set up automated trust checks:
GET nerq.ai/v1/preflight?target=blood-test-analyser-debug - Bekijk de license — Confirm that Blood Test Analyser Debug's license is compatible with your intended use case. Pay attention to restrictions on commercial use, redistribution, and derivative works. Some AI tools use dual licensing or have separate terms for enterprise customers that differ from the open-source license.
- Check community signals — Look at the project's issue tracker, discussion forums, and social media presence. A healthy community actively reports bugs, contributes fixes, and discusses beveiliging concerns openly. Low community engagement may indicate limited peer review of the codebase.
Common Safety Concerns with Blood Test Analyser Debug
When evaluating whether Blood Test Analyser Debug is safe, consider these category-specific risks:
Understand how Blood Test Analyser Debug processes, stores, and transmits your data. Bekijk de tool's privacy policy and data retention practices, especially for sensitive or proprietary information.
Check Blood Test Analyser Debug's dependency tree for known vulnerabilities. Tools with outdated or unmaintained dependencies pose a higher beveiliging risk.
Regularly check for updates to Blood Test Analyser Debug. Beveiliging patches and bug fixes are only effective if you're running the latest version.
If Blood Test Analyser Debug connects to external APIs or services, each integration point is a potential attack surface. Audit all third-party connections, verify that data shared with external services is minimized, and ensure that integration credentials are rotated regularly.
Verify that Blood Test Analyser Debug's license is compatible with your intended use case. Some AI tools have restrictive licenses that limit commercial use, redistribution, or derivative works. Using Blood Test Analyser Debug in violation of its license can expose your organization to legal liability.
Blood Test Analyser Debug and the EU AI Act
Blood Test Analyser Debug is classified as Minimal Risk under the EU AI Act. This is the lowest risk category, meaning it faces minimal regulatory requirements. However, transparency obligations still apply.
Nerq's naleving assessment covers 52 jurisdicties worldwide. For organizations deploying AI tools in regulated environments, understanding these classifications is essential for legal naleving.
Best Practices for Using Blood Test Analyser Debug Safely
Whether you're an individual developer or an enterprise team, these practices will help you get the most from Blood Test Analyser Debug while minimizing risk:
Periodically review how Blood Test Analyser Debug is used in your workflow. Check for unexpected behavior, permissions drift, and naleving with your beveiliging policies.
Ensure Blood Test Analyser Debug and all its dependencies are running the latest stable versions to benefit from beveiliging patches.
Grant Blood Test Analyser Debug only the minimum permissions it needs to function. Avoid granting admin or root access.
Subscribe to Blood Test Analyser Debug's beveiliging advisories and vulnerability disclosures. Use Nerq's API to get automated trust score updates.
Create and maintain a clear policy for how Blood Test Analyser Debug is used within your organization, including data handling guidelines and acceptable use cases.
Situations That Warrant Independent Review of Blood Test Analyser Debug
Nerq's signals are one input. In the following situations, evaluate Blood Test Analyser Debug's measured signals against your own requirements before making a decision:
- Environments handling sensitive or regulated data (healthcare, finance, government)
- Mission-critical systems where downtime has significant business impact
- Deployments with strict regulatory requirements that must be independently validated
For each situation, compare Blood Test Analyser Debug's measured trust score of 53.9/100 and its individual signals against your organization's own criteria. Nerq does not assert whether Blood Test Analyser Debug is suitable for any particular use.
How Blood Test Analyser Debug Compares to Industry Standards
Nerq indexes over 6 million software tools, apps, and packages across dozens of categories. Among health tools, the average Trust Score is 62/100. Blood Test Analyser Debug's score of 53.9/100 is near the category average of 62/100.
This places Blood Test Analyser Debug in line with the typical health tool tool. It meets baseline expectations but does not distinguish itself from peers on trust metrics.
Industry benchmarks matter because they contextualize a tool's safety profile. A score that looks matig in isolation may actually represent strong performance within a challenging category — or vice versa. Nerq's category-relative analysis helps teams make informed decisions by showing not just absolute quality, but how a tool ranks against its direct peers.
Trust Score History
Nerq continuously monitors Blood Test Analyser Debug and recalculates its Trust Score as new data becomes available. Our scoring engine ingests real-time signals from source repositories, vulnerability databases (NVD, OSV.dev), package registries, and community metrics. When a new CVE is published, a major release ships, or onderhoud patterns change, Blood Test Analyser Debug's score is updated within 24 hours.
Historical trust trends reveal whether a tool is improving, stable, or declining over time. A tool that consistently maintains or improves its score demonstrates ongoing commitment to beveiliging and quality. Conversely, a downward trend may signal reduced onderhoud, growing technical debt, or unresolved vulnerabilities. To track Blood Test Analyser Debug's score over time, use the Nerq API: GET nerq.ai/v1/preflight?target=blood-test-analyser-debug&include=history
Nerq retains trust score snapshots at regular intervals, enabling trend analysis across weeks and months. Enterprise users can access detailed historical reports showing how each dimension — beveiliging, onderhoud, documentatie, naleving, and community — has evolved independently, providing granular visibility into which aspects of Blood Test Analyser Debug are strengthening or weakening over time.
Blood Test Analyser Debug vs Alternatieven
In the health category, Blood Test Analyser Debug scores 53.9/100. There are higher-scoring alternatives available. For a detailed comparison, see:
- Blood Test Analyser Debug vs MedicalGPT — Trust Score: 52.2/100
- Blood Test Analyser Debug vs open-health — Trust Score: 52.2/100
- Blood Test Analyser Debug vs Awesome-AI4Med — Trust Score: 50.2/100
Belangrijkste conclusies
- Blood Test Analyser Debug has a measured Nerq Trust Score of 53.9/100 (D) — a composite of independent signals, not a suitability judgment.
- Among health tools, Blood Test Analyser Debug scores near the category average of 62/100 (a positional measurement relative to peers).
- The individual signals — beveiliging, onderhoud, documentatie, naleving, community — are shown above. Weigh them against your own requirements.
- Query the current measured values via Nerq's Preflight API.
Veelgestelde vragen
Is Blood Test Analyser Debug veilig?
Wat is de vertrouwensscore van Blood Test Analyser Debug?
Wat zijn veiligere alternatieven voor Blood Test Analyser Debug?
Hoe vaak wordt de beveiligingsscore van Blood Test Analyser Debug bijgewerkt?
Kan ik Blood Test Analyser Debug gebruiken in een gereguleerde omgeving?
Zie ook
Disclaimer: Nerq-vertrouwensscores zijn geautomatiseerde beoordelingen op basis van openbaar beschikbare signalen. Ze vormen geen aanbeveling of garantie. Voer altijd uw eigen verificatie uit.